C3 raises $10m

CLINICAL Cell Culture has raised $10 million after completing a share placement of 28.6 million fully paid ordinary shares to Australian investors.At an issue price of 35 cents a share, the placement represented a discount of 33 per cent to the three-month volume-weighted average price for C3 shares